A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
Verastem, Inc.
Verastem, Inc.
Dispatch Biotherapeutics
Pfizer
National Institutes of Health Clinical Center (CC)
Genmab
M.D. Anderson Cancer Center
Anthos Therapeutics, Inc.
Memorial Sloan Kettering Cancer Center
BigHat Biosciences, Inc.
National Institutes of Health Clinical Center (CC)
Boehringer Ingelheim
Montefiore Medical Center
The New York Proton Center
Nammi Therapeutics Inc
Janssen Research & Development, LLC
Revolution Medicines, Inc.
Bayer
University of Wisconsin, Madison
Alliance for Clinical Trials in Oncology
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
National Institutes of Health Clinical Center (CC)
Turning Point Therapeutics, Inc.
GlaxoSmithKline
University of Southern California
Abramson Cancer Center at Penn Medicine
Revolution Medicines, Inc.
Memorial Sloan Kettering Cancer Center
NYU Langone Health
City of Hope Medical Center
Erasca, Inc.
Baylor College of Medicine
Baylor College of Medicine
Baylor College of Medicine
Centre Oscar Lambret
National Institutes of Health Clinical Center (CC)
Wake Forest University Health Sciences
Brigham and Women's Hospital
Arbele Limited
Dana-Farber Cancer Institute
Merck Sharp & Dohme LLC
Massachusetts General Hospital
Varian, a Siemens Healthineers Company
Institut du Cancer de Montpellier - Val d'Aurelle
Indiana University
Dana-Farber Cancer Institute
M.D. Anderson Cancer Center
University of Miami
Mayo Clinic
University of Chicago
Merck Sharp & Dohme LLC